Tag Archives: Novartis

Novartis Leads Nationwide Effort to Bring Breast Cancer Awareness and Early Detection to UAE Workplaces

In collaboration with the Friends of Cancer Patients’ Pink Caravan, the initiative promotes workplace wellbeing with the participation of hundreds of employees across key sectors to prioritize early screening.

Dubai, United Arab Emirates, 8 December 2025  Novartis, in collaboration with Friends of Cancer Patients’ Pink Caravan, led a UAE-wide campaign brining awareness and on-site screening directly to workplaces. While October highlighted a key moment during Breast Cancer Awareness Month, the campaign’s impact extends well beyond it—continuing to promote early detection and sustain community awareness across the United Arab Emirates.

Continue reading Novartis Leads Nationwide Effort to Bring Breast Cancer Awareness and Early Detection to UAE Workplaces

Understanding lipoprotein(a) and its genetic impact on the heart

A call for early testing and broader public awareness

Media webinar titled “Introducing the Little (a) with Big Consequences” warned that one in five people unknowingly carry a genetic risk for heart disease, stressing the urgent need for greater awareness and screening.

Dubai, United Arab Emirates, 24 September 2025 — Novartis today convened leading experts from science, policy, patient advocacy, and clinical care to spotlight elevated lipoprotein(a), or Lp(a) – a little-known but highly prevalent genetic risk factor for cardiovascular disease (CVD) that affect 1 in 5 people worldwide.1 

The global educational webinar, titled “Introducing the Little (a) with Big Consequences”, was attended by journalists from leading media publications across the UAE. Held ahead of World Heart Day (29 September 2025), the session was part of a global awareness campaign by Novartis in collaboration with Global Heart Hub to raise awareness of elevated lipoprotein(a) and advance equitable access to testing and care worldwide.

Continue reading Understanding lipoprotein(a) and its genetic impact on the heart

Emirates Oncology Society, Novartis Launch New Partnership to Transform Breast Cancer Care in the UAE

Emirates Oncology Society, Novartis Launch New Partnership to Transform Breast Cancer Care in the UAE

‘United for Breast Cancer – A Commitment for Excellence and Innovation’ aims to address critical areas in breast cancer diagnosis, management, patient journeys, and local data generation.

30 October 2023; Dubai, United Arab Emirates — Novartis, a focused, innovative medicines company, and the Emirates Oncology Society (EOS) announced this week the launch of their partnership for United for Breast Cancer – A Commitment for Excellence and Innovation. The pioneering partnership aims to transform the landscape of breast cancer care in the UAE and generate local data to enhance the treatment and care of breast cancer patients across the emirates.

Breast cancer is the most common cancer in the world and in the Gulf, with the average age of diagnosis in the UAE being around 10 years younger than in Western countries.

Continue reading Emirates Oncology Society, Novartis Launch New Partnership to Transform Breast Cancer Care in the UAE